Prolyl 4-hydroxylase subunit alpha-2 acts as a TRIM21 ubiquitination substrate to promote papillary thyroid cancer progression via the glycolytic pathway
Abstract Papillary thyroid cancer (PTC), the predominant thyroid cancer, exhibits different adverse outcomes. However, the underlying molecular mechanisms of PTC remain inadequately elucidated. An integrative analysis of multiple mRNA-seq datasets from Gene Expression Omnibus and The Cancer Genome A...
Saved in:
| Main Authors: | Fengping Wu, Qian Liu, Jinkang Zhang, Dongkun Xu, Xue Jiang, Kun Zhang, YaZheng Chen, Xuliang Xia, Zhiqiang Jiang, Yuhong Shi, Wenling Tu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07702-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological prolyl hydroxylase inhibition enhances high‐intensity exercise capacity in mice
by: Koji Takemura, et al.
Published: (2025-07-01) -
Hypoxia-inducible factor-prolyl hydroxylase inhibitors in treatment of anemia with chronic disease
by: Zuolin Li, et al.
Published: (2025-06-01) -
Issues on clinical application of hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat
by: TU Yan, et al.
Published: (2020-01-01) -
Collagen prolyl 4-hydroxylase subunit α member-induced head and neck squamous cell carcinoma aggressiveness is antagonized by LLGL2 via reduced expression of occludin
by: Xu Miao, et al.
Published: (2024-10-01) -
Mitochondrial fission produces a Warburg effect via the oxidative inhibition of prolyl hydroxylase domain-2
by: Xutong Sun, et al.
Published: (2025-04-01)